Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle-invasive Transitional Cell Carcinoma of the Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07726602
What this trial is testing

Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
OHSU Knight Cancer Institute 100
Early research (Phase 1)Study completedNCT02720367
What this trial is testing

Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Urinary Bladder Cancer
Taris Biomedical LLC 12
Not applicableLooking for participantsNCT06170177
What this trial is testing

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Who this might be right for
Muscle-Invasive Bladder CarcinomaMuscle Invasive Bladder Urothelial CarcinomaBladder Cancer TNM Staging+14 more
IRCCS San Raffaele 4,000
Not applicableNot Yet RecruitingNCT07053722
What this trial is testing

Observational Clinical Study of Patients With Muscle - Invasive Bladder Cancer Undergoing Bladder Preservation Therapy After Neoadjuvant Therapy

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Peking University First Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00526656
What this trial is testing

Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
Case Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07064863
What this trial is testing

A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.

Who this might be right for
NMIBCNon-Muscle Invasive Bladder Urothelial CarcinomaBladder (Urothelial, Transitional Cell) Cancer+1 more
Queen's University 31
Not applicableStudy completedNCT06020807
What this trial is testing

Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

Who this might be right for
Non Muscle Invasive Bladder CancerNon-Muscle Invasive Bladder Urothelial Carcinoma
Nucleix Ltd. 168
Large-scale testing (Phase 3)Active Not RecruitingNCT03775265
What this trial is testing

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaMuscle Invasive Bladder CarcinomaStage II Bladder Cancer AJCC v8+1 more
National Cancer Institute (NCI) 475
Not applicableUnknownNCT05503563
What this trial is testing

A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder

Who this might be right for
Bladder Cancer
Assiut University 50
Early research (Phase 1)WithdrawnNCT02723838
What this trial is testing

Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder

Who this might be right for
Muscle-invasive Transitional Cell Carcinoma of the Bladder
Oncolytics Biotech
Testing effectiveness (Phase 2)Ended earlyNCT01094496
What this trial is testing

The CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)

Who this might be right for
Bladder Cancer
Celldex Therapeutics 3
Not applicableUnknownNCT03138824
What this trial is testing

Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC

Who this might be right for
Bladder Urothelial CarcinomaTURBTBladder Neoplasm+1 more
Mansoura University 100
Large-scale testing (Phase 3)Looking for participantsNCT05037279
What this trial is testing

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

Who this might be right for
Bladder CancerBladder Cancer RecurrentNeoplasm Recurrence+3 more
Verity Pharmaceuticals Inc. 540
Testing effectiveness (Phase 2)WithdrawnNCT03517995
What this trial is testing

Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention

Who this might be right for
Bladder CancerBladder TumorUrothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT05241340
What this trial is testing

Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma Bladder
The Methodist Hospital Research Institute 33
Early research (Phase 1)Study completedNCT02808143
What this trial is testing

Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Recurrent Bladder CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+1 more
Northwestern University 9
Large-scale testing (Phase 3)Active Not RecruitingNCT03244384
What this trial is testing

Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

Who this might be right for
Localized Renal Pelvis and Ureter Urothelial CarcinomaLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis and Ureter Urothelial Carcinoma+8 more
National Cancer Institute (NCI) 739
Not applicableNot Yet RecruitingNCT07817173
What this trial is testing

Feasibility of HISA During TURBT for NMIBC

Who this might be right for
Bladder CancerBladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)Non-muscle Invasive Bladder Cancer (NMIBC)+6 more
CAMC Health System 40
Large-scale testing (Phase 3)Ended earlyNCT01438112
What this trial is testing

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer

Who this might be right for
Transitional Cell CarcinomaBladder CancerCarcinoma in Situ+1 more
CG Oncology, Inc. 22
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Next Page